glp-1 medications market comparison Receptor Agonist Market: Exploring Opportunities North America Glucagon-Like Peptide-1 (GLP-1)

As of May 2023, Ozempic and Wegovy are both listed on FDAs Drug Shortages list

WollenbergABarbarotSBieberTChristen-ZaechSDeleuranMFink-WagnerAet al

Other medications that help reduce blood sugar are also possible alternatives, including: DPP-4 inhibitors like linagliptin (Tradjenta) and sitagliptin (Januvia) SGLT2 inhibitors like empagliflozin (Jardiance) and dapagliflozin (Farxiga) Sulfonylureas like glimepiride (Amaryl) and glyburide (Diabeta) TZDs like rosiglitazone (Avandia) and pioglitazone (Actos) Mounjaro warnings and precautions According to the FDA, some rare but serious issues have occurred in clinical trial participants, and those include: Pancreatitis Hypoglycemia Hypersensitivity reactions Acute kidney injury Severe gastrointestinal disease Diabetic retinopathy complications Acute gallbladder disease Talk to your provider to ensure you arent at a higher risk for those possible complications

[1] [2] It is also licensed for adolescents aged 12 years and above who meet specific criteria

Some patients feel that B12 shots provide a very sustained and consistent energy level throughout the week but like to supplement and augment this effect with oral forms on particularly stressful days